Metabolism of CDRI-85/92, a New Potent Anti-ulcer Agent, Involving Cis-Trans Conversion

P. Srivastava,; P. Sharma,; J. Lal,; D.K. Dikshit,; K.P. Madhusudanan,; R.C. Gupta,

doi:10.1515/DMDI.2004.20.1-2.57

Home Metabolism of CDRI-85/92, a New Potent Anti-ulcer Agent, Involving Cis-Trans Conversion

Article

Licensed

Unlicensed Requires Authentication

Metabolism of CDRI-85/92, a New Potent Anti-ulcer Agent, Involving Cis-Trans Conversion

P. Srivastava, , P. Sharma, , J. Lal, , D.K. Dikshit, , K.P. Madhusudanan, and R.C. Gupta,

Published/Copyright: June 1, 2004

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information

From the journal Drug Metabolism and Drug Interactions Volume 20 Issue 1-2

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

Srivastava,, P., Sharma,, P., Lal,, J., Dikshit,, D.K., Madhusudanan,, K.P. and Gupta,, R.C.. "Metabolism of CDRI-85/92, a New Potent Anti-ulcer Agent, Involving Cis-Trans Conversion" Drug Metabolism and Drug Interactions, vol. 20, no. 1-2, pp. 57-76. https://doi.org/10.1515/DMDI.2004.20.1-2.57

Srivastava,, P., Sharma,, P., Lal,, J., Dikshit,, D., Madhusudanan,, K. & Gupta,, R. (). Metabolism of CDRI-85/92, a New Potent Anti-ulcer Agent, Involving Cis-Trans Conversion. Drug Metabolism and Drug Interactions, 20(1-2), 57-76. https://doi.org/10.1515/DMDI.2004.20.1-2.57

Srivastava,, P., Sharma,, P., Lal,, J., Dikshit,, D., Madhusudanan,, K. and Gupta,, R. () Metabolism of CDRI-85/92, a New Potent Anti-ulcer Agent, Involving Cis-Trans Conversion. Drug Metabolism and Drug Interactions, Vol. 20 (Issue 1-2), pp. 57-76. https://doi.org/10.1515/DMDI.2004.20.1-2.57

Srivastava,, P., Sharma,, P., Lal,, J., Dikshit,, D.K., Madhusudanan,, K.P. and Gupta,, R.C.. "Metabolism of CDRI-85/92, a New Potent Anti-ulcer Agent, Involving Cis-Trans Conversion" Drug Metabolism and Drug Interactions 20, no. 1-2 (): 57-76. https://doi.org/10.1515/DMDI.2004.20.1-2.57

Srivastava, P, Sharma, P, Lal, J, Dikshit, D, Madhusudanan, K, Gupta, R. Metabolism of CDRI-85/92, a New Potent Anti-ulcer Agent, Involving Cis-Trans Conversion. Drug Metabolism and Drug Interactions. ;20(1-2): 57-76. https://doi.org/10.1515/DMDI.2004.20.1-2.57

Copy

Copied to clipboard

BibTeX EndNote RIS

Published Online: 2004-06

You are currently not able to access this content.

Articles in the same Issue

CONTENTS
The Effect of Cysteine Analogues on the Excretion of Urinary Sulphate in the Rat Following Cysteine Administration
Intravenous Pharmacokinetics and Metabolism of the Reactive Oxygen Scavenger α-Phenyl-N-Tert-Butyl Nitrone (PBN) in the Cynomolgus Monkey
Effect of Gemfibrozil on the Metabolism of Pitavastatin - Determining the Best Animal Model for Human CYP And UGT Activities
Effects of Chinese, Japanese and Western Tea on Hepatic P450 Enzyme Activities in Rats
Metabolism of CDRI-85/92, a New Potent Anti-ulcer Agent, Involving Cis-Trans Conversion
Impact of Truncated Area Under the Curve on Failed Bioequivalence Studies: A Computer Simulation Analysis
Estimation of Absorption Rate Constant (ka) Following Oral Administration by Wagner-Nelson, Loo-Riegelman, and Statistical Moments in the Presence of a Secondary Peak
In Vitro Susceptibility of Candida Species Isolated from Cancer Patients to Some Antifungal Agents
Book Review

Search journal Search the content of this journal

https://doi.org/10.1515/DMDI.2004.20.1-2.57

Articles in the same Issue

CONTENTS
The Effect of Cysteine Analogues on the Excretion of Urinary Sulphate in the Rat Following Cysteine Administration
Intravenous Pharmacokinetics and Metabolism of the Reactive Oxygen Scavenger α-Phenyl-N-Tert-Butyl Nitrone (PBN) in the Cynomolgus Monkey
Effect of Gemfibrozil on the Metabolism of Pitavastatin - Determining the Best Animal Model for Human CYP And UGT Activities
Effects of Chinese, Japanese and Western Tea on Hepatic P450 Enzyme Activities in Rats
Metabolism of CDRI-85/92, a New Potent Anti-ulcer Agent, Involving Cis-Trans Conversion
Impact of Truncated Area Under the Curve on Failed Bioequivalence Studies: A Computer Simulation Analysis
Estimation of Absorption Rate Constant (ka) Following Oral Administration by Wagner-Nelson, Loo-Riegelman, and Statistical Moments in the Presence of a Secondary Peak
In Vitro Susceptibility of Candida Species Isolated from Cancer Patients to Some Antifungal Agents
Book Review